Skip to results
Modify your search
NARROW
1-6 of 6
Authors: Anand Singla
Journal Article
Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn’s Disease Free
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 309–313, https://doi.org/10.1093/ibd/izab176
Published: 04 August 2021
Journal Article
P089 REAL-WORLD EXPERIENCE: CLINICAL AND ENDOSCOPIC EFFECTIVENESS OF STANDARD VEDOLIZUMAB DOSING AND MODIFIED MAINTENANCE DOSING IN PATIENTS WITH MODERATE-SEVERE CROHN’S DISEASE Get access
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S75, https://doi.org/10.1093/ibd/zaa010.187
Published: 23 January 2020
Journal Article
Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease Get access
Inflammatory Bowel Diseases, Volume 25, Issue 12, December 2019, Pages 1990–1995, https://doi.org/10.1093/ibd/izz100
Published: 14 May 2019
Journal Article
P136 CERTOLIZUMAB PEGOL IS EFFECTIVE IN THE MAINTENANCE OF RESPONSE IN MODERATE-SEVERE ULCERATIVE COLITIS: AN OPEN-LABEL MAINTENANCE STUDY Get access
Inflammatory Bowel Diseases, Volume 24, Issue suppl_1, February 2018, Page S49, https://doi.org/10.1093/ibd/izy037.004
Published: 18 January 2018
Journal Article
P142 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL TO EVALUATE INDUCTION OF CLINICAL RESPONSE IN PATIENTS WITH MODERATE-SEVERE CROHN’S DISEASE TREATED WITH RIFAXIMIN Get access
Inflammatory Bowel Diseases, Volume 24, Issue suppl_1, February 2018, Page S51, https://doi.org/10.1093/ibd/izy037.010
Published: 18 January 2018
Journal Article
Surgery for Ulcerative Colitis Is Associated with a High Rate of Readmissions at 30 Days Get access
Inflammatory Bowel Diseases, Volume 21, Issue 9, 1 September 2015, Pages 2130–2136, https://doi.org/10.1097/MIB.0000000000000473
Published: 27 May 2015
